Survival and cost‐effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER–Medicare database-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Survival and cost‐effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER–Medicare database

Published:2016-11-25 Issue:1 Volume:65 Page:122-133
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Parikh Neehar D.¹,Marshall Vincent D.²,Singal Amit G.³,Nathan Hari⁴,Lok Anna S.¹,Balkrishnan Rajesh⁵,Shahinian Vahakn⁶

Affiliation:

1. Division of GastroenterologyUniversity of MichiganAnn Arbor MI

2. College of PharmacyUniversity of MichiganAnn Arbor MI

3. Division of Digestive and Liver DiseaseUT Southwestern Medical CenterDallas TX

4. Department of SurgeryUniversity of MichiganAnn Arbor MI

5. Department of Public Health SciencesUniversity of VirginiaCharlottesville VA

6. Kidney Epidemiology and Cost CenterUniversity of MichiganAnn Arbor MI

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.28881

Reference34 articles.

1. Hepatocellular Carcinoma

2. Management of hepatocellular carcinoma: An update

3. Sorafenib in Advanced Hepatocellular Carcinoma

4. Safety and efficacy of sorafenib in patients with Child-Pugh B advanced hepatocellular carcinoma

5. GIDEON (Global Investigation of therapeutic DE cisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness of a Biomarker-Based Screening Strategy for Hepatocellular Carcinoma in Patients with Cirrhosis;Liver Cancer;2024-06-18

2. Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update;Journal of Clinical Oncology;2024-05-20

3. Treating liver cancer through arginine depletion;Drug Discovery Today;2024-04

4. Cost-Effectiveness Comparison of Carbon-Ion Radiation Therapy and Transarterial Chemoembolization for Hepatocellular Carcinoma;Advances in Radiation Oncology;2024-04

5. Cost-utility analysis of atezolizumab combined with bevacizumab for unresectable hepatocellular carcinoma in Thailand;PLOS ONE;2024-03-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3